Camden Asset Management Portfolio holdings

Camden Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Camden Asset Management held 97 positions worth $2.79B, down 17% from $3.38B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Camden Asset Management withdrew a net $2.12B in Q2 2020, closing 8 positions and reducing 11 holdings. Its most notable exit was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6, an estimated $227M position sold in full.

By sector, the portfolio is most concentrated in Utilities at 2.6% of assets, down from 3% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Camden Asset Management opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $37.3M.

• Camden Asset Management's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 355,500 shares worth $37.3M.
• Camden Asset Management added most to Bank of America Series L in Q2 2020, an estimated $62.4M increase.
• Camden Asset Management's biggest Q2 2020 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $83.2M.
• Camden Asset Management fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 in Q2 2020, selling an estimated $227M.
• Camden Asset Management's ten largest holdings make up 36% of its $2.79B portfolio in Q2 2020.
• Camden Asset Management opened 2 new positions and closed 8 in Q2 2020.
• Camden Asset Management's portfolio value fell 17% quarter-over-quarter to $2.79B.

Based on Camden Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.